| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,,
* Department of Pharmacology, University of Minnesota, Minneapolis, MN 55455;
Department of Surgery, Veterans Affairs Medical Center, Minneapolis, MN 55417; and
North Memorial Medical Center, Robbinsdale, MN 55422
Psychological stress is associated with immunosuppression in both
humans and animals. Although it was well established that psychological
stressors stimulate the hypothalamic-pituitary-adrenal axis and the
sympathetic nervous system, resulting in the release of various
hormones and neurotransmitters, the mechanisms underlying these
phenomena are poorly understood. In this study, µ-opioid receptor
knockout (MORKO) mice were used to investigate whether the µ-opioid
receptor mediates the immunosuppression induced by restraint stress.
Our results showed that wild-type (WT) mice subjected to chronic 12-h
daily restraint stress for 2 days exhibited a significant decrease in
splenocyte number with a substantial increase in apoptosis and CD95
(Fas/APO-1) expression of splenocytes. The effects are essentially
abolished in MORKO mice. Furthermore, inhibition of splenic lymphocyte
proliferation, IL-2, and IFN-
production induced by restraint stress
in WT mice was also significantly abolished in MORKO mice.
Interestingly, both stressed WT and MORKO mice showed a significant
elevation in plasma corticosterone and pituitary proopiomelanocortin
mRNA expression, although the increase was significantly lower in MORKO
mice. Adrenalectomy did not reverse restraint stress-induced
immunosuppression in WT mice. These data clearly established that the
µ-opioid receptor is involved in restraint stress-induced immune
alterations via a mechanism of apoptotic cell death, and that the
effect is not mediated exclusively through the glucocorticoid
pathway.
This article has been cited by other articles:
|
|
 |
|
  D. Chakass, D. Philippe, E. Erdual, S. Dharancy, M. Malapel, C. Dubuquoy, X. Thuru, J. Gay, C. Gaveriaux-Ruff, P. Dubus, et al. {micro}-Opioid receptor activation prevents acute hepatic inflammation and cell death Gut, July 1, 2007; 56(7): 974 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Charleston, R. Puana, R. K. McAllister, F. A. Hunter, and E. W. Childs Morphine sulfate attenuates hemorrhagic shock- induced hyperpermeability. Anesth. Analg., July 1, 2006; 103(1): 156 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kelschenbach, R. A. Barke, and S. Roy Morphine Withdrawal Contributes to Th Cell Differentiation by Biasing Cells Toward the Th2 Lineage J. Immunol., August 15, 2005; 175(4): 2655 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matsuzaki, M. Canis, C. Vaurs-Barriere, J.L. Pouly, O. Boespflug-Tanguy, F. Penault-Llorca, P. Dechelotte, B. Dastugue, K. Okamura, and G. Mage DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection Mol. Hum. Reprod., October 1, 2004; 10(10): 719 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hoffman-Goetz, J. Quadrilatero, J. Boudreau, and J. Guan Adrenalectomy in mice does not prevent loss of intestinal lymphocytes after exercise J Appl Physiol, June 1, 2004; 96(6): 2073 - 2081. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
